The effect of antibiotic therapy on the results of biopsy in me
Phase 3
Recruiting
- Conditions
- Prostate Cancer.Malignant neoplasm of prostate
- Registration Number
- IRCT20180915041037N1
- Lead Sponsor
- Yazd University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 80
Inclusion Criteria
Patients older than 40 years of age with prostate-specific antigen (PSA) in the range of 4-15 ng/ml
Patients with normal digital rectal examination (DRE)
Patients without Irritative and obstructive urinary symptoms
Patients with informed consent
Exclusion Criteria
Patients undergoing rectal biopsy (TRUS) during the past month.
Patients who have ejaculation in the past 28 hours.
Patients who have undergone urological surgeries during the past six months.
Patients with a history of prostate cancer or clinical and laboratory evidence
Patients with a history of taking 5-alpha-blockers such as Finasteride in the past six weeks
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PSA levels above 4 ng / ml. Timepoint: One month after referring to the specialist. Method of measurement: Blood test.
- Secondary Outcome Measures
Name Time Method Biopsy results. Timepoint: One month after referring to the specialist. Method of measurement: Standard biopsy (12-core).